We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Siemens Celebrates Success of Urine Chemistry Analyzer

By Labmedica staff writers
Posted on 16 Jul 2008
Placement of the 50,000th Clinitek Status urine chemistry analyzer, manufactured by Siemens (Sudbury, UK), was specially marked with a commemorative plaque handed over by Donal Quinn, CEO of Siemens Healthcare Diagnostics, to Lynda Petley, point-of-care manager, Partnership Pathology Services (Frimley, UK) at a ceremony held to mark the occasion.

"This 50,000th placement marks a milestone for Siemens. More...
The Clinitek Status analyzer has been popular amongst customers since launched in November 2003, and continues to be adopted because it fulfils customers' needs for automated, accurate urinalysis readings.” commented Mr. Quinn.

To mark the occasion, a commemorative gold medal was presented to the production site and employees were each given a gold medal. Celebratory events will also take place at the Siemens R&D sites in Elkhart, IN, and Edgewater, MA (USA).

Clinik Status urine analyzers provide important markers to detect early stages of many disease states, such as diabetes, kidney disease, and urinary tract infections. They are used in both secondary and primary care settings. They are robust, simple to use, cost-effective, and provide accurate results transferred in printouts to lab personnel.


Related Links:
Siemens Healthcare Diagnostics
Partnership Pathology Services

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.